NIH-funded research R01 grant

Investigating how respiratory viruses affect lung health in transplant patients

Official title: Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients

Funded at Fred Hutchinson Cancer Center · NIH-10995284 · Data updated 2026-11-12

This study is looking at how respiratory viruses affect lung health in people who have had a stem cell transplant and are dealing with bronchiolitis obliterans syndrome, and it will use home devices to keep track of their lung function over time to help catch any problems early.

More Transplant research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startDecember 1, 2021
Project endNovember 30, 2026
Funding year2025
Award (this year)$668,582
NIH project number5R01HL161037-05
Project IDNIH-10995284 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have received an allogeneic hematopoietic cell transplant and are at risk for bronchiolitis obliterans syndrome.

Less likely to help

Patients who have not undergone allogeneic hematopoietic cell transplantation or do not have respiratory complications may not benefit from this research.

What this research studies

This research focuses on understanding the impact of respiratory viruses on bronchiolitis obliterans syndrome (BOS) in patients who have undergone allogeneic hematopoietic cell transplantation. It aims to identify how these viruses contribute to lung dysfunction and poor health outcomes over time. By using mobile wireless home spirometry, the study will monitor lung function in patients, allowing for early diagnosis and better tracking of disease progression. The research will involve multiple centers and will follow patients longitudinally to gather comprehensive data on their respiratory health.

Why it matters

Potential benefit: If successful, this research could lead to improved management and treatment strategies for lung complications in transplant patients.

How similar studies have gone: Previous research has indicated that monitoring respiratory viruses can provide valuable insights into lung health, suggesting that this approach may yield significant findings.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Cheng, Guang-Shing — Fred Hutchinson Cancer Center
  • Study coordinator: Cheng, Guang-Shing

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.